Abstract Due to the cancer therapy-related cardiovascular toxicity. heart failure following cancer therapy has a significant mortality rate. Gene-targeted therapy promotes the re-entry of existing cardiomyocytes into the cell cycle to achieve myocardial regeneration. which is a promising strategy for preventing and treating heart failure after myocardial infarction. https://www.alarecre.com/